CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population

Biomarkers

Volumn 2, Issue 2, 1997, Pages 131-134

  Bouchardy, Christine ^a   Wikman, Harriet ^b   Benhamou, Simone ^c   Hirvonen, Ari ^b   Dayer, Pierre ^d   Husgafvel Pursiainen, Kirsti ^b  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cancer susceptibility; CYP1A1; Genetic polymorphism; Lung cancer; Smoking

Indexed keywords

EID: 0000935488     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475097231869     Document Type: Article

References (17)

1. ALEXANDRIE, A-K., SUNDBERG, M. I., SEIDEGARD, J., TORNLING, G. AND RANNUG, A. (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15, 1785-1790.
2. BAKER, R. J AND NELDER, J. A. (1978) Generalized linear interactive modelling (GLIM) system. Release 3 (Oxford, Numerical Algorithms Group).
3. BOUCHARDY, C., BENHAMOU, S. AND DAYER, P. (1996) The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Research, 56, 251-253.
4. BRESLOW, N. E. AND DAY, N. E. (1980) The analysis of case-control studies. In Statistical Methods in Cancer Research, Vol. 1, No. 32, IARC Scientific Publications (International Agency for Research on Cancer, Lyon), pp. 192-242.
5. CROFTS, E., COSMA, G. N., CURRIE, D., TAIOLI, E., TONIOLO, P. AND GARTE, S. J. (1993) A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis, 14, 1729-1731.
6. CROFTS, E., TAIOLI, E., TRACHMAN, J., COSMA, G. N., CURRIE, D., TONIOLO, P. AND GARTE, S. J. (1994) Functional significance of different CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
7. D'ERRICO, A., TAIOLI, E., CHEN, X. AND VINEIS, P. (1996) Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1, 149-173.
8. DRAKOULIS, N., CASCORBI, I., BROCKMÖLLER, J., GROSS, C. R. AND ROOTS, I. (1994) Polymorphisms in the human CY1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clinical Investigator, 72, 240-248.
9. HAMADA, G. S., SUGIMURA, H., SUZUKI, I., NAGURA, K., KIYOKAWA, E., IWASE, T., TANAKA, M., TAKAHASHI, T., WATANABE, S., KINO, I. AND TSUGANE, S. (1995) The heme-binding region polymorphism of cytochrome P450IA1 (CyplA1),rather than the Rsal polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiology, Biomarkers & Prevention, 4, 63-67.
10. HAYASHI, S. I., WATANABE, J., NAKACHI, K. AND KAWAJIRI, K. (1991) Genetic linkage of lung cancer-associated Mspl polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. Journal of Biochemistry, 110, 407-411.
11. HAYASHI, S. I., WATANABE, J. AND KAWAJIRI, K. (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Japanese Journal of Cancer Research, 83, 866-870.
12. HIRVONEN, A., HUSGAFVEL-PURSIANEN, K., KARJALAINEN, A., ANTTILA, S. AND VAINIO, H. (1992) Point-mutational Mspl and IIe-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiology, Biomarkers & Prevention, 1, 485-489.
13. NAKACHI, K., IMAI, K., HAYASHI, S. AND KAWAJIRI, K. (1993) Polymorphisms of the CYP1A1 and glutathione S-Transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Research, 53, 2994-2999.
14. OYAMA, T., MITSUDOMI, T., KAWAMOTO, T., OGAMI, A., OSAKI, T., KODOMA, Y. AND YASUMOTO, Y. (1995) Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. International Archives of Occupational and Environmental Health, 67, 253-256.
15. SHIELDS, P. G., CAPORASO, N. E., FALK, R. T., SUGIMURA, H., TRIVERS, G. E., TRUMP, B. F., HOOVER, R. N., WESTON, A. AND HARRIS, C. C. (1993) Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiology, Biomarkers & Prevention, 2, 481-485.
16. 1450) gene: lack of association between the Mspl restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1, 20-25.
17. YUN, C. H., SHIMADA, T. AND GUENGERICH, F. P. (1992) Role of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo (a)pyrene. Cancer Research, 52, 1868-1874.